Jason Minio

Paralegal Specialist
Full contact info

Experience

Alto Neuroscience Announces $147.9 Million IPO

February 6, 2024

Cooley advised Alto Neuroscience, a company redefining psychiatry by leveraging individuals’ neurobiology to develop personalized and highly effective medicines and helping patients get better faster, on its $147.9 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Christina T. Roupas
Partner in Charge – Chicago, Chicago
Courtney M.W. Tygesson
Partner, Chicago
Laurie Bauer
Partner, Chicago
Nyron J. Persaud
Partner, New York
Kate Hillier
Partner, Seattle
Jon Cousin
Partner, Washington, DC
Elizabeth Anne Wright
Partner, Brussels
Eileen Marshall
Partner, Washington, DC
Geoffrey Spolyar
Partner, Boston
Stephanie Gentile
Partner, New York
Steve Flores
Partner, Chicago
Peter Adams
Partner, San Diego
Phil Mitchell
Partner, New York
Courtney Thorne
Partner, Boston
David Navetta
Partner, Colorado
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Katie Lapidus
Associate, Washington, DC
Trey Reilly
Associate, New York
Adam Bloom
Associate, Chicago
David D. Suh
Associate, Palo Alto
Dionne A. Thomas
Associate, San Diego
Megan E. Bowles
Associate, Chicago
Mor Agam
Associate, New York
Nat Sherrick
Associate, Washington, DC
Edmond Lay
Associate, San Diego
Addison Pierce
Associate, Chicago
Calvin Lee
Associate, New York
Andrew Nelms
Associate, San Francisco
Jason Minio
Paralegal Specialist, Boston
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Blue Owl Capital Invests up to $1.05 Billion in BridgeBio Pharma

January 17, 2024

Cooley advised Blue Owl Capital, a top asset manager redefining alternatives, on its strategic investment a $300 million royalty financing and a $450 million credit facility in BridgeBio Pharma, a commercial-stage biopharmaceutical company focused on genetic diseases and cancers.

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Michael Tollini
Partner, Washington, DC
Addison Pierce
Associate, Chicago
Matt Kong
Associate, San Francisco
Ivor Elrifi
Partner, New York
Xander Lee
Partner, Los Angeles Santa Monica
Geoffrey Spolyar
Partner, Boston
Jon Cousin
Partner, Washington, DC
Steve Flores
Partner, Chicago
Phil Mitchell
Partner, New York
Michael Egan
Partner, Washington, DC
Jeffrey J. Tolin
Partner, New York
Michael Klein
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Robert Eisenbach
Of Counsel, San Francisco
Susan Piascik Christoff
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Cathy Hershcopf
Senior Counsel, New York
Stevie Yu
Associate, New York
Yichao Zhang
Associate, New York
Rodrigo Huerta
Associate, Chicago
Jackson Alldredge
Associate, Colorado
Amanda Pacheco
Associate, Palo Alto
Celine Koh
Associate, Palo Alto
Jameson Davis
Associate, Palo Alto
Allison Kutner
Associate, New York
Matthew S. Scarano
Associate, San Diego
Xueqing Li
Associate, San Francisco
Mor Agam
Associate, New York
Miriam Peguero Medrano
Associate, Chicago
Sam Rabuck
Associate, Chicago
Chris Rhem
Paralegal Specialist, San Francisco
Veronica Cortes
Paralegal Specialist, New York
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC
Jason Minio
Paralegal Specialist, Boston
Jeffery Wyzykowski
Patent Agent, Washington, DC

Related Practices & Industries

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, New York
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington, DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington, DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington, DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington, DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington, DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

General Catalyst Leads Helsings 209 Million Euro Series B Financing

September 14, 2023

Cooley advised General Catalyst Partners, a venture capital firm providing early-stage and growth equity investments, as the lead investor in Helsing’s 209 million euro Series B financing.

Read more

Related contacts

Pat Mitchell
Partner, Boston
Michael McGrail
Partner, Boston
Eric Popp
Associate, Boston
Stephanie McFarland
Associate, Boston
Caroline Hobson
Partner, London
Chris Coulter
Partner, London
Aaron Pomeroy
Partner, Colorado
David Fletcher
Partner, Washington, DC
James Maton
Partner, London
Kevin King
Partner, Washington, DC
Matthew Smith
Partner, Boston
Christopher Kimball
Partner, Washington, DC
Christine Graham
Special Counsel, London
Annie Froehlich
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Grant Schweikert
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Jan Lang
Associate, Brussels
Anna Caro
Associate, London
Marzia Di Candido
Associate, London
Juan Nascimbene
Associate, London
María Álvarez Requejo Heredero
Associate, Brussels
Rick Jantz
Associate, Los Angeles Santa Monica
Randwulf P. Singleton
Associate, Colorado
Jason Minio
Paralegal Specialist, Boston

Related Practices & Industries

Braze – $572 Million IPO

November 24, 2021

Cooley advised customer engagement platform Braze on its $572 million initial public offering of 8,800,000 shares of Class A common stock, which now trade on the Nasdaq Global Select Market under the symbol BRZE. Lawyers Nicole Brookshire, Jodie Bourdet, Peter Byrne and Owen Williams led the team advising Braze.

Read more

Related contacts

Jodie Bourdet
Partner, San Francisco
Peter Byrne
Partner, New York
Sacha Ross
Partner, New York
Andrew Gunther
Associate, New York
Jayne M. Munger
Associate, New York
Jill Simon
Senior Paralegal, New York
Jason Minio
Paralegal Specialist, Boston
Cathy Rude
Paralegal Specialist, Boston
Megan Browdie
Partner, Washington, DC
Rubin Waranch
Associate, Washington, DC
Barbara Mirza
Partner, Los Angeles Santa Monica
Paula Holland
Partner, London
Nicola Squire
Partner, London
Wendy Brenner
Partner, Palo Alto
Amis Pan
Associate, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Len Jacoby
Partner, New York
Eileen Marshall
Partner, Washington, DC
Stephanie Gentile
Partner, New York
David Navetta
Partner, Colorado
Claire Gibbs
Associate, Washington, DC
Amy Collins
Special Counsel, London
Francis Wheeler
Partner, Colorado

Related Practices & Industries

View more